176 related articles for article (PubMed ID: 33903625)
1. Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.
Kulkarni O; Sugier PE; Guibon J; Boland-Augé A; Lonjou C; Bacq-Daian D; Olaso R; Rubino C; Souchard V; Rachedi F; Lence-Anta JJ; Ortiz RM; Xhaard C; Laurent-Puig P; Mulot C; Guizard AV; Schvartz C; Boutron-Ruault MC; Ostroumova E; Kesminiene A; Deleuze JF; Guénel P; De Vathaire F; Truong T; Lesueur F
Sci Rep; 2021 Apr; 11(1):8932. PubMed ID: 33903625
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study on differentiated thyroid cancer.
Köhler A; Chen B; Gemignani F; Elisei R; Romei C; Figlioli G; Cipollini M; Cristaudo A; Bambi F; Hoffmann P; Herms S; Kalemba M; Kula D; Harris S; Broderick P; Houlston R; Pastor S; Marcos R; Velázquez A; Jarzab B; Hemminki K; Landi S; Försti A
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1674-81. PubMed ID: 23894154
[TBL] [Abstract][Full Text] [Related]
3. Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
Truong T; Lesueur F; Sugier PE; Guibon J; Xhaard C; Karimi M; Kulkarni O; Lucotte EA; Bacq-Daian D; Boland-Auge A; Mulot C; Laurent-Puig P; Schvartz C; Guizard AV; Ren Y; Adjadj E; Rachédi F; Borson-Chazot F; Ortiz RM; Lence-Anta JJ; Pereda CM; Comiskey DF; He H; Liyanarachchi S; de la Chapelle A; Elisei R; Gemignani F; Thomsen H; Forsti A; Herzig AF; Leutenegger AL; Rubino C; Ostroumova E; Kesminiene A; Boutron-Ruault MC; Deleuze JF; Guénel P; de Vathaire F
Int J Cancer; 2021 Jun; 148(12):2935-2946. PubMed ID: 33527407
[TBL] [Abstract][Full Text] [Related]
4. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.
Guibon J; Sugier PE; Kulkarni O; Karimi M; Bacq-Daian D; Besse C; Boland A; Adjadj E; Rachédi F; Rubino C; Xhaard C; Mulot C; Laurent-Puig P; Guizard AV; Schvartz C; Ortiz RM; Ren Y; Ostroumova E; Deleuze JF; Boutron-Ruault MC; Kesminiene A; De Vathaire F; Guénel P; Lesueur F; Truong T
Oncotarget; 2021 Mar; 12(5):493-506. PubMed ID: 33747362
[TBL] [Abstract][Full Text] [Related]
5. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
[TBL] [Abstract][Full Text] [Related]
6. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
Figlioli G; Köhler A; Chen B; Elisei R; Romei C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Försti A; Gemignani F
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2084-92. PubMed ID: 25029422
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.
Son HY; Hwangbo Y; Yoo SK; Im SW; Yang SD; Kwak SJ; Park MS; Kwak SH; Cho SW; Ryu JS; Kim J; Jung YS; Kim TH; Kim SJ; Lee KE; Park DJ; Cho NH; Sung J; Seo JS; Lee EK; Park YJ; Kim JI
Nat Commun; 2017 Jul; 8():15966. PubMed ID: 28703219
[TBL] [Abstract][Full Text] [Related]
8. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
9. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
[TBL] [Abstract][Full Text] [Related]
10. Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.
Pereda CM; Lesueur F; Pertesi M; Robinot N; Lence-Anta JJ; Turcios S; Velasco M; Chappe M; Infante I; Bustillo M; García A; Clero E; Xhaard C; Ren Y; Maillard S; Damiola F; Rubino C; Salazar S; Rodriguez R; Ortiz RM; de Vathaire F
BMC Genet; 2015 Mar; 16():22. PubMed ID: 25879635
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of GWAS variants associated with differentiated thyroid cancer.
Jendrzejewski JP; Sworczak K; Comiskey DF; de la Chapelle A
Endokrynol Pol; 2019; 70(5):423-429. PubMed ID: 31681970
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma.
Figlioli G; Elisei R; Romei C; Melaiu O; Cipollini M; Bambi F; Chen B; Köhler A; Cristaudo A; Hemminki K; Gemignani F; Försti A; Landi S
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):700-13. PubMed ID: 26843521
[TBL] [Abstract][Full Text] [Related]
13. Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.
Figlioli G; Chen B; Elisei R; Romei C; Campo C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Gemignani F; Försti A
Sci Rep; 2015 Mar; 5():8922. PubMed ID: 25753578
[TBL] [Abstract][Full Text] [Related]
14. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
15. FOXE1 association with differentiated thyroid cancer and its progression.
Penna-Martinez M; Epp F; Kahles H; Ramos-Lopez E; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Holzer K; Bechstein WO; Zeuzem S; Vorländer C; Badenhoop K
Thyroid; 2014 May; 24(5):845-51. PubMed ID: 24325646
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.
Uimari O; Rahmioglu N; Nyholt DR; Vincent K; Missmer SA; Becker C; Morris AP; Montgomery GW; Zondervan KT
Hum Reprod; 2017 Apr; 32(4):780-793. PubMed ID: 28333195
[TBL] [Abstract][Full Text] [Related]
17. The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population.
Rogounovitch TI; Bychkov A; Takahashi M; Mitsutake N; Nakashima M; Nikitski AV; Hayashi T; Hirokawa M; Ishigaki K; Shigematsu K; Bogdanova T; Matsuse M; Nishihara E; Minami S; Yamanouchi K; Ito M; Kawaguchi T; Kondo H; Takamura N; Ito Y; Miyauchi A; Matsuda F; Yamashita S; Saenko VA
Thyroid; 2015 Mar; 25(3):333-40. PubMed ID: 25562676
[TBL] [Abstract][Full Text] [Related]
18. The Role of NRG1 in the Predisposition to Papillary Thyroid Carcinoma.
He H; Li W; Liyanarachchi S; Wang Y; Yu L; Genutis LK; Maharry S; Phay JE; Shen R; Brock P; de la Chapelle A
J Clin Endocrinol Metab; 2018 Apr; 103(4):1369-1379. PubMed ID: 29121253
[TBL] [Abstract][Full Text] [Related]
19. Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma.
Xu L; Doan PC; Wei Q; Liu Y; Li G; Sturgis EM
Thyroid; 2012 Jan; 22(1):35-43. PubMed ID: 22136207
[TBL] [Abstract][Full Text] [Related]
20. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma.
Xu L; Morari EC; Wei Q; Sturgis EM; Ward LS
J Clin Endocrinol Metab; 2012 Jun; 97(6):1913-21. PubMed ID: 22438227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
